| Species | Human |
| Product Type | iPS-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Brain (Cerebral) |
| Disease | Neurodegenerative diseases, Brain tumor, Neurodevelopmental disorders |
| Generation Process | Cerebral organoids derived from human pluripotent stem cells (hPSCs) are generated using advanced maturation technologies that support long-term culture and functional development. These optimized protocols enable extended studies of brain development, disease progression, and therapeutic response. |
| Organoid Characterization | Cerebral organoids effectively recapitulate the laminar organization of the developing human cortex, including the ventricular zone (VZ), subventricular zone (SVZ), intermediate zone (IZ), cortical plate (CP), and marginal zone (MZ), enabling investigation of neuronal differentiation, migration, and network formation. This makes them a valuable model for studying neurodevelopment and brain function. |
| Applications | They recapitulate essential structural and functional features of the human cortex, serving as a powerful tool for translational neuroscience research. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.